Large-scale testing (Phase 3)Study completedNCT04509674
What this trial is testing
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
Who this might be right for
Myocardial Infarction
Boehringer Ingelheim 6,522